Skip to main content
Livermore
Livermore
ZHEN

McIlrath & Eck, LLC

SEC CIK
0001701714
Latest filing
May 19, 2026

TVRD holding history

Tvardi Therapeutics, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVRD overviewAll 13F holders of TVRDFull Q1 2026 holdings

Shares (Q1 2026)
20
Value
$64
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TVRD by McIlrath & Eck, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 202620$64<0.1%00.0%UnchangedHolders
Q4 202520$86<0.1%00.0%UnchangedHolders
Q3 202520$779<0.1%00.0%UnchangedHolders
Q2 202520$467<0.1%−0−1.6%ReducedConverted for a 1-for-3 splitHolders
Q1 202561$309<0.1%00.0%UnchangedHolders
Q4 202461$375<0.1%−0−0.5%ReducedConverted for a 1-for-12 splitHolders
Q3 2024736$227<0.1%00.0%UnchangedHolders
Q2 2024736$190<0.1%00.0%UnchangedHolders
Q1 2024736$670<0.1%00.0%UnchangedHolders
Q4 2023736$547<0.1%00.0%UnchangedHolders
Q3 2023736$1.24K<0.1%00.0%UnchangedHolders
Q2 2023736$2.08K<0.1%00.0%UnchangedHolders
Q1 2023736$3.61K<0.1%00.0%UnchangedHolders
Q4 2022736$7.91K<0.1%00.0%UnchangedHolders
Q3 2022736$7.00K<0.1%00.0%UnchangedHolders
Q2 2022736$7.00K<0.1%00.0%UnchangedHolders
Q1 2022736$9.00K<0.1%−214−22.5%ReducedHolders
Q4 2021950$12.0K<0.1%00.0%UnchangedHolders
Q3 2021950$15.0K<0.1%00.0%UnchangedHolders
Q2 2021950$14.0K<0.1%+214+29.1%AddedHolders
Q1 2021736$16.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.